Sonodynamic Therapy in the Treatment of Carotid Atherosclerosis

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 5, 2019

Primary Completion Date

January 30, 2020

Study Completion Date

January 30, 2020

Conditions
Carotid Atherosclerosis
Interventions
COMBINATION_PRODUCT

Sonodynamic therapy (SDT)

Sinoporphyrin sodium (DVDMS) as sonosensitizer, is dissolved in 0.9% sodium solution for following skin test and intravenous injection. 0.01mg/ml DVDMS solution (0.1ml) is prepared for skin test followed by 0.04 mg/ml DVDMS solution intravenous injection (0.2mg/kg).The target atherosclerotic lesions are marked on the corresponding skin with ultrasound guidance and underwent ultrasound exposure after 4 hours incubation. The therapeutic ultrasonic transducer is fixed to the marked skin site for 15min of each lesion. Ultrasound parameters included intensity of 1.6W/cm2 for carotid lesions, resonance frequency: 1.0 MHz and duty factor: 30%.

Trial Locations (1)

150000

The First Affiliated Hospital of Harbin Medical University, Harbin

All Listed Sponsors
lead

First Affiliated Hospital of Harbin Medical University

OTHER

NCT03871725 - Sonodynamic Therapy in the Treatment of Carotid Atherosclerosis | Biotech Hunter | Biotech Hunter